All In Biotech

Drug Trial Radar · NCT00474240

AEGR-733 and Atorvastatin 20 mg vs. Monotherapy in Moderate Hypercholesterolemia

A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of the Combination of AEGR-733 (Formerly BMS201038) and Atorvastatin 20 mg vs. Monotherapy in Subjects With Moderate Hypercholesterolemia

Last checked: Nov 20, 2026Latest source record: Mar 20, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 157 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

157

Actual

Start

Apr 2007

Primary completion

Oct 2008

Study completion Oct 2008

Sponsor

Lead sponsor
Aegerion Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
May 16, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test the effectiveness of the study drug, AEGR-733 alone and in combination with the medication, atorvastatin (Lipitor), on cholesterol in volunteers with moderately high cholesterol.

Conditions

  • Hypercholesterolemia

Interventions

  • Atorvastatin 20 mgDrug

  • AEGR-733 5 mgDrug

  • AEGR-733 10 mgDrug

  • PlaceboDrug

  • AEGR-733 5 mg + atorvastatin 20 mgDrug

  • AEGR-733 10 mg + atorvastatin 20 mgDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in LDL-C at 8 WeeksTime frame: Atfer 8 weeks on study drug

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Medical Affiliated Research Center

    Huntsville, Alabama

  • Jacksonville Center for Clinical research

    Jacksonville, Florida

  • Jacksonville Center For Clinical Research

    Jacksonville, Florida

  • Renstar Medical Research

    Ocala, Florida

  • North Georgia Clinical Research

    Woodstock, Georgia

  • Radiant Research

    Chicago, Illinois

  • Medsphere Medical Research Center

    Evansville, Indiana

  • Midwest Institute for Clinical Research

    Indianapolis, Indiana

  • Maine Research Associates

    Auburn, Maine

  • Health Trends Research

    Baltimore, Maryland

  • Piedmont Medical Research Associates

    Winston-Salem, North Carolina

  • Sterling Research Group

    Cincinnati, Ohio

  • Coastal Carolina Research Center

    Goose Creek, South Carolina

  • Dallas Diabetes and Endocrine Center

    Dallas, Texas

  • Diabetes and Glandular Disease Research

    Dallas, Texas

  • Hampton Roads Center for Clinical Research

    Norfolk, Virginia

  • National Clinical Research

    Richmond, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.